CAV1 rs3807989: Understanding Your Genetic Variant
The rs3807989 variant is a single-nucleotide polymorphism located within the CAV1 gene. Research has identified statistical associations between this variant and the risk of developing atrial fibrillation, a common heart rhythm disorder.
What each genotype means
Typical cardiovascular and longevity profile
You carry two copies of the major G allele for rs3807989 in the CAV1 gene. In published genome-wide association studies, this genotype represents the standard baseline profile and is not associated with the increased risk of atrial fibrillation or altered caveolin-1 expression observed with the minor allele. However, individual cardiovascular health and healthspan depend heavily on comprehensive lifestyle factors and overall genetic background.
Carried by approximately 40% of individuals of European ancestry and roughly 50% to 55% of East Asian populations.
Moderately altered vascular risk profile
You carry one copy of the minor A allele and one copy of the major G allele. Large-scale genetic association studies have linked the A allele to modest shifts in cardiac electrophysiology, including altered PR interval duration and increased susceptibility to atrial fibrillation and coronary artery disease. Findings regarding its impact on metabolic traits and longevity show some variation across ancestries and reflect moderate population-level risk shifts rather than a medical diagnosis.
Carried by roughly 45% to 48% of individuals of European ancestry and about 40% of individuals in East Asian cohorts.
Elevated vascular and electrophysiological risk
You carry two copies of the minor A allele for rs3807989. Published research links this homozygous genotype to higher expression of CAV1, longer cardiac PR intervals, and increased statistical odds for atrial fibrillation and coronary artery disease compared to the baseline genotype. Because these findings represent statistical population associations, they do not determine your individual cardiovascular outcomes, which are strongly shaped by clinical and lifestyle factors.
Carried by approximately 12% to 15% of people of European ancestry and about 6% to 9% of individuals of East Asian ancestry.
What is rs3807989?
The rs3807989 variant is a specific change in the DNA sequence of the CAV1 gene, which is located on chromosome 7. In genetics, a single-nucleotide polymorphism (SNP) like rs3807989 represents a variation at a single position in the DNA building blocks. This particular variant involves a substitution between the G and A alleles. Scientists study these variations to understand how subtle differences in our genetic code might influence biological processes or susceptibility to certain health conditions. Because this variant is located within a gene that plays a critical role in cellular structure, researchers have focused on how it might alter the function or expression of the associated protein, caveolin-1, and whether these changes correlate with observable differences in cardiovascular health across different human populations.
The Role of the CAV1 Gene
The CAV1 gene provides instructions for producing a protein called caveolin-1. This protein is a primary component of caveolae, which are small, flask-shaped indentations found on the surface of many cell types, including those in the heart and blood vessels. Caveolin-1 acts as a structural scaffold and a regulator of various signaling pathways. It is known to interact with several ion channels, such as potassium and sodium channels, which are essential for maintaining the electrical stability of the heart. By modulating these channels, caveolin-1 helps regulate the electrical impulses that control the heartbeat. When the function of caveolin-1 is altered, it may affect the heart's electrical conduction system, potentially contributing to the development of arrhythmias like atrial fibrillation.
Research and Associations
Multiple studies have investigated the link between rs3807989 and atrial fibrillation (AF). Research, including genome-wide association studies (GWAS) and replication studies in various populations, has suggested that the G allele may be associated with an increased risk of AF. For instance, studies in Chinese Han and other populations have reported statistically significant associations between this variant and both general and 'lone' atrial fibrillation. However, it is important to note that genetic associations can vary significantly between different ethnic groups and ancestral backgrounds. While some studies have found a clear correlation, others have reported mixed or controversial results, highlighting the complexity of genetic risk factors. The evidence for this association is generally considered moderate, as it relies on statistical correlations that do not imply a direct cause-and-effect relationship for any single individual.
Population Frequency
The frequency of the rs3807989 variant varies across different global populations. According to data from large-scale genomic databases like gnomAD, the minor allele frequency is approximately 0.37 in European populations. This means that the variant is relatively common, and many individuals carry at least one copy of the minor allele. Because allele frequencies are influenced by evolutionary history and geographic ancestry, these numbers can differ significantly when comparing individuals of European, Asian, African, or other ancestries. Understanding these frequency differences is a key part of population genetics, as it helps researchers determine whether a specific genetic association is consistent across diverse groups or if it is unique to a particular population.
Interpreting Your Genetic Information
It is essential to understand that having a specific genotype for rs3807989 does not mean you will develop a heart condition. Genetic variants are only one piece of a much larger puzzle that includes lifestyle, environment, and other genetic factors. This information is for educational purposes and should not be used to diagnose or predict personal health outcomes. If you are concerned about your cardiovascular health or have questions about your risk for heart rhythm disorders, you should consult with a qualified healthcare professional. They can provide context based on your personal medical history, family history, and clinical symptoms. Never make changes to your health management or medication based on genetic data without first discussing it with your doctor or a licensed pharmacist.
How common is this variant?
The minor allele frequency for rs3807989 is approximately 0.37 in European populations, though this frequency varies across different global ancestries.
Frequently asked questions
Does having the G allele mean I will get atrial fibrillation?
No. Genetic variants like rs3807989 are associated with statistical risk, not certainty. Many people with the G allele never develop atrial fibrillation, and many people without it do.
Can I change my genotype for rs3807989?
No. Your genotype is determined at conception and remains the same throughout your life. You cannot alter your DNA sequence through diet or lifestyle.
Should I take medication based on my rs3807989 result?
Absolutely not. You should never start, stop, or change any medication based on genetic test results. Always discuss your health and any concerns with your doctor or pharmacist.
Is this variant the only cause of atrial fibrillation?
No. Atrial fibrillation is a complex condition influenced by many factors, including age, high blood pressure, heart disease, lifestyle, and numerous other genetic variants.
Sources & further reading
Educational information only, last refreshed 10/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3807989?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29